About
Lassogen develops engineered lasso peptides, called Lassotides™, as programmable medicines to create stable and selective therapeutic molecules targeting diseases inadequately treated by current therapies.
Explore Lassogen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.